Stock listing
Frankfurt:S7C StenoCare A/S Aktie
German listing (Frankfurt) of StenoCare A/S · home listing Copenhagen:STENO
Follow StenoCare A/S into a list and get an email when it puts out news.
Share price · FWB:S7C
€0.069 EUR -0.002 (-3.3%)
Close on Nov 20, 2026
- Day range
- €0.069 – €0.073 EURNov 20, 2026
- Market cap
- €3.00M EURAt the close on Nov 20, 2026 · price × 43.20M shares outstanding
- 52-week range
- €0.069 – €0.244 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €0 EURMedian day 0 shares · 57 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Copenhagen:STENO · Home | 0.59 DKK | -0.01 (-1.7%) | 94,302 | 0.56 | 0.624 | 0.532 | 0.60 | Close on Nov 20, 2026 |
| Frankfurt:S7C | €0.069 EUR | -0.002 (-3.3%) | — | €0.073 | €0.073 | €0.069 | €0.072 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:S7C · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.084 | +0.003 | +3.7% | €0.082 | €0.084 | €0.081 | 0 | |
| €0.081 | -0.011 | -12.0% | €0.091 | €0.092 | €0.081 | 0 | |
| €0.092 | 0.000 | 0.0% | €0.088 | €0.092 | €0.087 | 0 | |
| €0.092 | +0.005 | +5.7% | €0.093 | €0.094 | €0.091 | 0 | |
| €0.087 | -0.002 | -2.2% | €0.088 | €0.088 | €0.087 | 0 | |
| €0.089 | +0.002 | +2.3% | €0.089 | €0.089 | €0.089 | 0 | |
| €0.087 | +0.002 | +2.4% | €0.090 | €0.090 | €0.087 | 0 | |
| €0.085 | -0.005 | -5.6% | €0.086 | €0.090 | €0.085 | 0 | |
| €0.090 | +0.001 | +1.1% | €0.087 | €0.090 | €0.085 | 0 | |
| €0.089 | +0.006 | +7.2% | €0.090 | €0.090 | €0.087 | 0 | |
| €0.083 | -0.001 | -1.2% | €0.085 | €0.086 | €0.083 | 0 | |
| €0.084 | -0.007 | -7.7% | €0.084 | €0.084 | €0.084 | 0 | |
| €0.091 | +0.013 | +16.7% | €0.080 | €0.091 | €0.080 | 0 | |
| €0.078 | -0.004 | -4.9% | €0.076 | €0.079 | €0.076 | 0 | |
| €0.082 | +0.007 | +9.3% | €0.081 | €0.082 | €0.081 | 0 | |
| €0.075 | -0.005 | -6.3% | €0.078 | €0.078 | €0.075 | 0 | |
| €0.080 | -0.007 | -8.0% | €0.081 | €0.081 | €0.080 | 0 | |
| €0.087 | -0.003 | -3.3% | €0.088 | €0.088 | €0.087 | 0 | |
| €0.090 | -0.005 | -5.3% | €0.093 | €0.093 | €0.090 | 0 | |
| €0.095 | +0.001 | +1.1% | €0.095 | €0.097 | €0.095 | 0 | |
| €0.094 | +0.001 | +1.1% | €0.095 | €0.095 | €0.094 | 0 | |
| €0.093 | -0.004 | -4.1% | €0.091 | €0.094 | €0.091 | 0 | |
| €0.097 | +0.006 | +6.6% | €0.090 | €0.104 | €0.090 | 0 | |
| €0.091 | -0.015 | -14.2% | €0.105 | €0.106 | €0.090 | 0 | |
| €0.106 | -0.004 | -3.6% | €0.109 | €0.109 | €0.104 | 0 | |
| €0.110 | -0.005 | -4.3% | €0.112 | €0.112 | €0.110 | 0 | |
| €0.115 | -0.002 | -1.7% | €0.115 | €0.115 | €0.114 | 0 | |
| €0.117 | 0.000 | 0.0% | €0.116 | €0.118 | €0.116 | 0 | |
| €0.117 | 0.000 | 0.0% | €0.116 | €0.118 | €0.116 | 0 | |
| €0.117 | +0.002 | +1.7% | €0.116 | €0.117 | €0.115 | 0 | |
| €0.115 | 0.000 | 0.0% | €0.114 | €0.116 | €0.114 | 0 | |
| €0.115 | -0.001 | -0.9% | €0.116 | €0.116 | €0.115 | 0 | |
| €0.116 | +0.004 | +3.6% | €0.117 | €0.119 | €0.116 | 0 | |
| €0.112 | -0.001 | -0.9% | €0.114 | €0.115 | €0.111 | 0 | |
| €0.113 | -0.002 | -1.7% | €0.114 | €0.114 | €0.113 | 0 | |
| €0.115 | 0.000 | 0.0% | €0.115 | €0.117 | €0.115 | 0 | |
| €0.115 | +0.001 | +0.9% | €0.112 | €0.115 | €0.112 | 0 | |
| €0.114 | 0.000 | 0.0% | €0.113 | €0.114 | €0.113 | 0 | |
| €0.114 | +0.005 | +4.6% | €0.112 | €0.114 | €0.111 | 0 | |
| €0.109 | -0.005 | -4.4% | €0.116 | €0.116 | €0.109 | 0 | |
| €0.114 | +0.003 | +2.7% | €0.115 | €0.115 | €0.114 | 0 | |
| €0.111 | -0.008 | -6.7% | €0.117 | €0.118 | €0.110 | 0 | |
| €0.119 | +0.002 | +1.7% | €0.114 | €0.121 | €0.114 | 0 | |
| €0.117 | +0.001 | +0.9% | €0.111 | €0.117 | €0.109 | 0 | |
| €0.116 | -0.001 | -0.9% | €0.114 | €0.116 | €0.114 | 0 | |
| €0.117 | -0.001 | -0.8% | €0.117 | €0.117 | €0.116 | 0 | |
| €0.118 | 0.000 | 0.0% | €0.118 | €0.118 | €0.116 | 0 | |
| €0.118 | -0.002 | -1.7% | €0.118 | €0.118 | €0.117 | 0 | |
| €0.120 | +0.002 | +1.7% | €0.120 | €0.120 | €0.120 | 0 | |
| €0.118 | -0.004 | -3.3% | €0.118 | €0.118 | €0.118 | 0 | |
| €0.122 | +0.003 | +2.5% | €0.120 | €0.122 | €0.120 | 0 | |
| €0.119 | -0.003 | -2.5% | €0.122 | €0.122 | €0.119 | 0 | |
| €0.122 | -0.003 | -2.4% | €0.122 | €0.122 | €0.122 | 0 | |
| €0.125 | +0.002 | +1.6% | €0.125 | €0.125 | €0.124 | 0 | |
| €0.123 | -0.002 | -1.6% | €0.123 | €0.126 | €0.122 | 0 | |
| €0.125 | -0.001 | -0.8% | €0.128 | €0.128 | €0.124 | 0 | |
| €0.126 | -0.003 | -2.3% | €0.142 | €0.142 | €0.125 | 0 |
- Ticker
- Frankfurt:S7C
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Aug 20, 2026
STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter
Latest news
STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter
Aug 20, 2026
Closed €0.126 (-2.3%) on Aug 20, 2026
STENOCARE completes integration of CannGros ApS
Jul 3, 2026
Closed €0.129 (-0.8%) on Jul 6, 2026
Notice to Annual General Meeting in STENOCARE A/S
Apr 7, 2026
Closed €0.135 (+5.5%) on Apr 8, 2026
STENOCARE A/S publishes Annual Report 2025
Mar 26, 2026
Closed €0.15 (+38.9%) on Mar 26, 2026
Interim report fourth quarter and Financial Statement Release 2025
Feb 26, 2026
Closed €0.179 (+1.1%) on Feb 26, 2026
STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership
Feb 11, 2026
Closed €0.198 (+7.0%) on Feb 11, 2026
Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany
Jan 27, 2026
Closed €0.195 (+3.2%) on Jan 28, 2026
Trading in STENOCARE shares by closely related party to board member
Dec 30, 2025
Closed €0.194 (+1.0%) on Dec 30, 2025
Stenocare acquires Canngros
Nov 21, 2025
Closed €0.233 (-2.9%) on Nov 21, 2025
StenoCare A/S on 6ix
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- News releases
- 8 in the last 12 months · 18 in all · newest Aug 20, 2026 · oldest 2025
Where StenoCare A/S is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Copenhagen:STENO · Home listing | Copenhagen | Denmark | DKK |
| Frankfurt:S7C · This page | Frankfurt | Germany | EUR |
| Munich:S7C | Munich | Germany | EUR |
Valuation
EV/sales 2.0× against a median of 1.6×: 6th lowest of 11 Tobacco & cannabis companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 25.63M DKK
- P/E
- Loss
- EV/sales
- 2.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.2×
- Gross margin
- 18.0%
- Operating margin
- −10.5%
- Net margin
- −13.9%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Tobacco & cannabis: the 10 companies nearest in size, of 97 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| StenoCare A/S · OMXCOP:STENO | US$3.74M | US$3.76M | n/a | 2.0× | n/a | 3.2× | −13.9% | 0.1× | n/a |
| PharmaCielo Ltd. · TSXV:PCLO | US$5.39M | US$5.34M | n/a | 2.1× | n/a | n/a | −103.1% | n/a | -0.16 |
| Ecs Botanics Holdings Ltd · ASX:ECS | US$5.32M | US$8.44M | n/a | 0.6× | n/a | 0.3× | −9.1% | 0.3× | n/a |
| Avant Brands Inc · TSX:AVNT | US$5.13M | US$12.54M | n/a | 0.5× | n/a | 0.3× | −24.7% | 0.6× | 0.35 |
| Zelira Therapeutics Ltd. · ASX:ZLD | US$4.35M | US$5.76M | n/a | 13,283× | n/a | n/a | n/a | n/a | n/a |
| Enorama Pharma AB · OMXSTO:ERMA | US$4.29M | US$4.08M | n/a | 28.8× | n/a | n/a | n/a | n/a | n/a |
| Blueberries Medical Corp. · CSE:BBM | US$4.04M | US$4.03M | n/a | 20.8× | n/a | 202× | −384.3% | 0.0× | -0.18 |
| cbdMD, Inc. · AMEX:YCBD | US$4.03M | US$1.92M | n/a | 0.1× | n/a | 0.5× | −13.8% | 0.0× | 1.10 |
| Mercanto Holdings Inc · TSXV:MUSH | US$3.96M | US$3.59M | n/a | 1.1× | 87.6× | 11.5× | −0.1% | 0.0× | -0.47 |
| Christina Lake Cannabis Corp · CSE:CLC | US$3.46M | US$4.63M | n/a | 0.5× | n/a | 0.5× | −30.4% | 0.4× | 0.91 |
| Nicoccino Holding AB · OMXSTO:NICO | US$3.02M | US$2.88M | n/a | 35.3× | n/a | 21.9× | n/a | 0.5× | n/a |
| Median of the others | US$4.17M | US$4.36M | 1.6× | 87.6× | 0.5× | −24.7% | 0.3× | 0.09 |
Team and board
Officers
| Officer | Role |
|---|---|
| Thomas Skovlund Schnegelsberg | CEO |
| Peter Bugge Johansen | CFO |
| Rolf Steno Petersen | CCO and Co-Founder |
Board
| Director | Role |
|---|---|
| Marianne Wier | Non-executive Chairman of the Board of Directors |
| Henrik Elbæk Pedersen | Non-executive member of the Board of Directors |
| Jeppe Bo Petersen | Non-executive member of the Board of Directors |
| Rolf Steno Petersen | CCO and Co-Founder |
| Søren Melsing Frederiksen | Non-executive member of the Board of Directors |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2021 | May 6, 2021 | −6.8% |
Financials
Annual, in DKK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.02M | 2.23M | 3.76M | 4.49M | 1.57M | 198.4K | 8.78M | 4.14M |
| Cost of revenue | 8.83M | 20.7M | 10.2M | 10.9M | 15.7M | 12.3M | 11.4M | 7.74M |
| Gross profit | -1.81M | -18.5M | -6.42M | -6.41M | -14.1M | -12.1M | -2.63M | -3.59M |
| Selling, general and administrative | 7.41M | 5.27M | ||||||
| Operating income | -1.77M | -33.1M | -15.9M | -16.5M | -14.0M | -12.0M | 4.37M | -3.59M |
| Depreciation and amortization | 69.8K | 8.86M | 3.38M | 3.31M | 1.09M | 240.6K | 58.9K | 1.40K |
| EBITDA | -1.70M | -24.2M | -12.6M | -13.2M | -13.0M | -11.8M | 4.43M | -3.59M |
| Interest expense | 658.3K | 1.54M | 2.88M | 1.29M | 213.2K | 1.68M | 2.12M | 12.6K |
| Income before tax | -2.39M | -34.6M | -18.8M | -17.9M | -14.3M | -13.7M | 2.25M | -3.61M |
| Income tax | -108.3K | -1.25M | -1.58M | -1.53M | -1.93M | 544.0K | -328.7K | |
| Net income | -2.39M | -34.5M | -17.6M | -16.3M | -12.7M | -11.8M | 1.70M | -3.28M |
| Earnings per share, basic | -0.06 | -1.00 | -1.26 | -1.35 | -1.05 | -1.06 | 0.17 | -0.33 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 787.4K | 1.38M | 9.50M | 4.43M | 11.7M | 26.4M | 21.7M | 18.1M |
| Short-term investments | -488.4K | |||||||
| Receivables | 3.00M | 1.80M | 3.92M | 4.70M | 1.84M | 599.0K | 637.8K | 3.05M |
| Inventory | 307.0K | 319.6K | 45.6K | 727.9K | 18.4K | 0 | 0 | 84.2K |
| Current assets | 4.71M | 5.26M | 14.9M | 13.1M | 15.1M | 29.2M | 22.8M | 21.7M |
| Property, plant and equipment | 26.0M | 28.4M | 26.7M | 626.8K | 19.6K | |||
| Goodwill | 7.58M | |||||||
| Total assets | 12.6M | 19.7M | 38.1M | 39.6M | 43.9M | 56.3M | 31.6M | 21.7M |
| Accounts payable | 410.3K | 1.81M | 1.48M | 2.51M | 1.19M | 1.44M | 816.3K | 602.9K |
| Current liabilities | 3.17M | 7.49M | 11.4M | 9.61M | 2.71M | 3.69M | 18.1M | 1.24M |
| Long-term debt | 0 | 1.97M | 0 | 3.53M | 0 | |||
| Total debt | 1.99M | 3.73M | 9.68M | 11.3M | 1.24M | 80.0K | 16.6M | |
| Total liabilities | 3.17M | 23.2M | 12.3M | 15.5M | 3.69M | 3.77M | 18.1M | 1.24M |
| Shareholders' equity | 9.47M | -3.47M | 25.8M | 24.1M | 40.2M | 52.6M | 13.5M | 20.5M |
| Shares outstanding | 43.2M | 34.5M | 13.9M | 12.1M | 12.1M | 11.1M | 10.1M | 10.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -7.21M | -7.14M | -10.0M | -15.0M | -13.3M | -12.7M | -2.54M | -5.57M |
| Capital spending | -4 | -44.4K | -176.4K | -935.9K | -3.27M | -18.5M | -8.39M | -21.0K |
| Free cash flow | -7.21M | -7.19M | -10.2M | -16.0M | -16.6M | -31.2M | -10.9M | -5.60M |
| Cash from investing | -364.6K | -28.2K | -176.6K | -936.8K | -2.54M | -18.5M | -8.88M | -27.0K |
| Cash from financing | 6.98M | -948.5K | 15.3M | 8.68M | 1.24M | 35.9M | 15.0M | 23.7M |
| Change in cash | -593.2K | -8.12M | 5.07M | -7.29M | -14.6M | 4.63M | 3.58M | 18.1M |
Cap table
Built by 6ix from StenoCare A/S’ releases
- Common shares
- 43,195,978
- Fully diluted
- 43,195,978
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 43,195,978 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 43,195,978 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Henrik Elbæk Pedersen | Non-executive member of the Board of Directors · Since at least Apr 7, 2026 |
| Jeppe Bo Petersen | Non-executive member of the Board of Directors · Since at least Apr 7, 2026 |
| Marianne Wier | Non-executive Chairman of the Board of Directors · Since at least Apr 7, 2026 |
| Peter Bugge Johansen | CFO · Since at least Mar 26, 2026 |
| Rolf Steno Petersen | CCO and Co-Founder · Since at least Apr 7, 2026 |
| Søren Melsing Frederiksen | Non-executive member of the Board of Directors · Since at least Apr 7, 2026 |
| Thomas Skovlund Schnegelsberg | CEO · Since at least Aug 20, 2026 |
| Ulrik Bayer | chairman of the meeting · May 15, 2025 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about StenoCare A/S.